Enabling proactive cardiovascular health management
Our patented ultra-sensitive immunoassay technology enhances the clinical utility of biomarkers implicated for cardiac dysfunction, vascular inflammation and dysfunction, dyslipidemia, and cardiometabolic disorders, which provides greater resolution to test results and supports better patient care.
Advanced Cardiovascular Disease Testing and Wellness Management Services
- Proprietary high-precision Single Molecule Counting (SMCTM) technology allows for unprecedented insight to assess patient risk.
- Broad coverage of available biomarkers provide comprehensive and functional assessment of patient cardiovascular health.
- Commitment to cutting edge research promises future clinically valuable additions to our test menu.
- CVMedHome.com helps physicians and patients effectively manage chronic disease and monitor disease progression.
Contact us to learn more
Toll Free: 800.400.4344
Information herein pertains to testing performed by or for the Singulex Clinical Laboratory. Singulex proprietary lab developed tests (Sgx HD tests, sd-LDL, HDL2b, Lp(a), Adiponectin, and Leptin) were developed and performance characteristics were determined by Singulex. These tests have not been cleared or approved by the U.S. Food and Drug Administration.